Actinium-225 Market Research Report | Valuates Reports

Actinium-225 Market

Actinium-225 (225Ac, Ac-225) is an isotope of actinium. It undergoes alpha decay to francium-221 with a half-life of 10 days, and is an intermediate decay product in the neptunium series (the decay chain starting at 237Np). Except for minuscule quantities arising from this decay chain in nature, 225Ac is entirely synthetic.
The decay properties of actinium-225 are favorable for usage in targeted alpha therapy (TAT); clinical trials have demonstrated the applicability of radiopharmaceuticals containing 225Ac to treat various types of cancer. However, the scarcity of this isotope resulting from its necessary synthesis in cyclotrons limits its potential applications.
The global Actinium-225 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

View Sample Report
https://reports.valuates.com/request/sample/QYRE-Auto-35M13954/Global_Actinium_225_Market_Research_Report_2023

Report Scope
The Actinium-225 market size, estimations, and forecasts are provided in terms of output/shipments (mCi) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Actinium-225 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Actinium-225 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Regional Report
https://reports.valuates.com/request/regional/QYRE-Auto-35M13954/Global_Actinium_225_Market_Research_Report_2023

Segment by Type
• Accelerator
• Thorium-229 Decay

Segment by Application
• Scientific Research
• Cancer Therapy

By Company
ORNL, Tri-Lab, SSC RF-IPPE, JRC Karlsruhe, TerraPower, TRIUMF, Eckert&Ziegler

View Full Report
https://reports.valuates.com/market-reports/QYRE-Auto-35M13954/global-actinium-225

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.